Feasibility Study, Number Of Lagoons

No definition available.

Name:	pfe_FeasibilityStudyNumberOfLagoons
Namespace Prefix:	pfe_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Loss Contingency, Collaboration Arrangement, Percentage of Payments Sought by Plaintiff

+ References

No definition available.

+ Details

Name:	pfe_LossContingencyCollaborationArrangementPercentageofPaymentsSoughtbyPlaintiff
Namespace Prefix:	pfe_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of judgment or settlement awarded to (against) the entity in respect of litigation.

+ References

No definition available.

+ Details

Name:	us-gaap_LitigationSettlementAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_LossContingenciesLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of claims dismissed.

+ References

No definition available.

+ Details

Name:	us-gaap_LossContingencyClaimsDismissedNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of another entity's patents that the entity has allegedly infringed.

+ References

No definition available.

+ Details

Name:	us-gaap_LossContingencyPatentsAllegedlyInfringedNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of pending claims pertaining to a loss contingency.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14435-108349

+ Details

Name:	us-gaap_LossContingencyPendingClaimsNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Details

Name:	us-gaap_ProductOrServiceAxis=pfe_InflectraMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LitigationCaseAxis=pfe_JanssenandNewYorkUniversityVersusHospiraCelltrionHealthcareandCelltrionInc.Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ProductOrServiceAxis=pfe_XtandiMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LitigationCaseAxis=pfe_RegentsVersusMedivationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_DamagesFromProductDefectsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LitigationCaseAxis=pfe_ClassActionVersusAmericanOpticalCorporationAndVariousOtherDefendantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LossContingenciesByNatureOfContingencyAxis=pfe_AverageWholesalePriceMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LitigationCaseAxis=pfe_StateofIllinoisVersusPfizerMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LossContingenciesByNatureOfContingencyAxis=pfe_EnvironmentalRemediationLitigationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LossContingenciesByNatureOfContingencyAxis=pfe_ViolationofAntitrustLawsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ProductOrServiceAxis=pfe_PhenytoinSodiumCapsulesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Commitments and Contingencies (Actions In Which We Are The Defendant) (Detail) £ in Millions	1 Months Ended
	Dec. 31, 2016 GBP (£)	Mar. 31, 2015 Patents	Apr. 30, 2014	Mar. 31, 2013 lagoon	Apr. 02, 2017 Claim
Inflectra [Member] \| Janssen and New York University Versus Hospira, Celltrion Healthcare and Celltrion Inc. [Member]
Loss Contingencies [Line Items]
Number of patents		6
Inflectra [Member] \| Janssen and New York University Versus Hospira, Celltrion Healthcare and Celltrion Inc. [Member] \| Pending Litigation [Member]
Loss Contingencies [Line Items]
Number of patents		2
Inflectra [Member] \| Janssen and New York University Versus Hospira, Celltrion Healthcare and Celltrion Inc. [Member] \| Settled Litigation [Member]
Loss Contingencies [Line Items]
Claims dismissed		4
Xtandi [Member] \| Regents Versus Medivation [Member] \| Pending Litigation [Member]
Loss Contingencies [Line Items]
Percentage of payments Medivation received sought by Regents			10.00%
Damages from Product Defects [Member] \| Class Action Versus American Optical Corporation And Various Other Defendants [Member] \| Pending Litigation [Member]
Loss Contingencies [Line Items]
Number of pending claims \| Claim					56,300
Average Wholesale Price [Member] \| State of Illinois Versus Pfizer [Member] \| Pending Litigation [Member]
Loss Contingencies [Line Items]
Number of pending claims \| Claim					1
Environmental Remediation Litigation [Member]
Loss Contingencies [Line Items]
Number of lagoons \| lagoon				2
Violation of Antitrust Laws [Member] \| Phenytoin Sodium Capsules [Member]
Loss Contingencies [Line Items]
Fine imposed by CMA \| £	£ 84.2